Table 1.
Group allocation for the hepatoprotective study.
Groups | Drug Administered |
---|---|
1 | Negative Control |
2 | Toxic Control; CCl4(2 mL/kg, Intraperitonially, in Olive Oil) |
3 | Positive Control; Silymarin (Orally) |
4 | BB-160 (Orally) |
5 | BB-APSP-40 (Orally) |
6 | BB-APSP-80 (Orally) |
BB = Berberine, BB-APSP = Berberine nanoparticles prepared by antisolvent method.